CHEBI:71019 - omacetaxine mepesuccinate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name omacetaxine mepesuccinate
ChEBI ID CHEBI:71019
Definition A cephalotaxine-derived alkaloid ester obtained from Cephalotaxus harringtonia; used for the treatment of chronic or accelerated phase chronic myeloid leukaemia.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C29H39NO9
Net Charge 0
Average Mass 545.62130
Monoisotopic Mass 545.26248
InChI InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1
InChIKey HYFHYPWGAURHIV-JFIAXGOJSA-N
SMILES [H][C@@]12[C@H](OC(=O)[C@@](O)(CCCC(C)(C)O)CC(=O)OC)C(OC)=C[C@@]11CCCN1CCc1cc3OCOc3cc21
Roles Classification
Biological Role(s): anticoronaviral agent
Any antiviral agent which inhibits the activity of coronaviruses.
protein synthesis inhibitor
A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via alkaloid )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing omacetaxine mepesuccinate (CHEBI:71019) has functional parent cephalotaxine (CHEBI:3540)
omacetaxine mepesuccinate (CHEBI:71019) has role anticoronaviral agent (CHEBI:149553)
omacetaxine mepesuccinate (CHEBI:71019) has role antineoplastic agent (CHEBI:35610)
omacetaxine mepesuccinate (CHEBI:71019) has role apoptosis inducer (CHEBI:68495)
omacetaxine mepesuccinate (CHEBI:71019) has role protein synthesis inhibitor (CHEBI:48001)
omacetaxine mepesuccinate (CHEBI:71019) is a alkaloid ester (CHEBI:38481)
omacetaxine mepesuccinate (CHEBI:71019) is a enol ether (CHEBI:47985)
omacetaxine mepesuccinate (CHEBI:71019) is a organic heteropentacyclic compound (CHEBI:38164)
omacetaxine mepesuccinate (CHEBI:71019) is a tertiary alcohol (CHEBI:26878)
INNs Sources
mépésuccinate d'omacétaxine WHO MedNet
mepesuccinato de omacetaxina WHO MedNet
omacetaxine mepesuccinate WHO MedNet
omacetaxini mepesuccinas WHO MedNet
Synonyms Sources
(−)-homoharringtonine ChEBI
(2'R,3S,4S,5R)-(−)-homoharringtonine ChEBI
CGX-635 ChemIDplus
Homoharringtonine KEGG DRUG
Brand Name Source
Synribo ChemIDplus
Manual Xrefs Databases
4677 DrugCentral
D08956 KEGG DRUG
HMT PDBeChem
LSM-3716 LINCS
Omacetaxine_mepesuccinate Wikipedia
US2010240887 Patent
WO2007089878 Patent
View more database links
Registry Numbers Types Sources
26833-87-4 CAS Registry Number ChemIDplus
26833-87-4 CAS Registry Number KEGG DRUG
5687925 Reaxys Registry Number Reaxys
5687925 Beilstein Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
20971952 PubMed citation Europe PMC
21152934 PubMed citation Europe PMC
21258877 PubMed citation Europe PMC
21294709 PubMed citation Europe PMC
21415308 PubMed citation Europe PMC
21418889 PubMed citation Europe PMC
21468038 PubMed citation Europe PMC
21509439 PubMed citation Europe PMC
21845438 PubMed citation Europe PMC
21916787 PubMed citation Europe PMC
22040954 PubMed citation Europe PMC
22054289 PubMed citation Europe PMC
22075327 PubMed citation Europe PMC
22289991 PubMed citation Europe PMC
22391162 PubMed citation Europe PMC
22580751 PubMed citation Europe PMC
22714632 PubMed citation Europe PMC
22896000 PubMed citation Europe PMC
22898909 PubMed citation Europe PMC
22917222 PubMed citation Europe PMC
22967374 PubMed citation Europe PMC
23053254 PubMed citation Europe PMC
23059828 PubMed citation Europe PMC
23086639 PubMed citation Europe PMC
23109844 PubMed citation Europe PMC
23456623 PubMed citation Europe PMC
Last Modified
23 April 2020